Symptoms of Low Vitamin E: Causes and Treatment
Deficiency
Symptoms & causes
Vitamin E deficiency is rare in healthy adults eating a normal diet, but is a significant risk in people with fat-malabsorption conditions (Crohn's disease, cystic fibrosis, liver disease) and certain genetic disorders; neurological symptoms (ataxia, peripheral neuropathy) are the most serious consequence.
Vitamin E is a fat-soluble antioxidant critical for nerve and muscle function. While deficiency is uncommon in healthy adults, it can cause progressive neurological damage in people with conditions that impair fat absorption, such as cystic fibrosis or Crohn's disease. This guide covers the symptoms, genetic causes, diagnosis, treatment, and the evidence-based role of high-dose vitamin E in fatty liver disease.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Symptoms of low Vitamin E — a fat-soluble vitamin and the body's primary lipid-soluble antioxidant, comprising eight naturally occurring forms: four tocopherols (alpha, beta, gamma, delta) and four tocotrienols. Alpha-tocopherol is the only form maintained in human blood and tissues at meaningful levels and the only form the body uses to meet vitamin E requirements — it is the form in supplements and the basis of the RDA. RDA for adults: 15 mg (22.4 IU) alpha-tocopherol/day; UL: 1,000 mg/day from supplements (due to anticoagulant effects at high doses). Dietary sources: vegetable oils (wheat germ oil is the richest source — roughly 20 mg per tablespoon; sunflower oil, safflower oil, soybean oil); nuts and seeds (almonds: roughly 7 mg per oz; sunflower seeds); green leafy vegetables (spinach, broccoli — modest amounts); fortified cereals.
Everyday signs are on the left; the ones on the right mean it's time to check in with a clinician.
Everyday signs
Common symptoms
- Peripheral neuropathy (numbness, tingling, loss of proprioception)
- Spinocerebellar ataxia (progressive loss of coordination and balance — the hallmark of severe deficiency)
- Muscle weakness (myopathy)
- Retinal damage (retinopathy)
- Impaired immune response (particularly in older adults)
- In premature infants (the population at highest risk): hemolytic anemia, retrolental fibroplasia, and intraventricular hemorrhage
Don't wait
See a doctor if
- Any new or progressive neurological symptoms — ataxia (loss of balance/coordination), weakness, loss of proprioception, or sensory neuropathy — require clinical evaluation with serum alpha-tocopherol measurement, especially in anyone with fat-malabsorption conditions.
- Hemolytic anemia in premature infants requires immediate neonatal care.
Who is most likely to run low
Some people are more prone to falling short than others — including many people on a weight-loss journey who are simply eating less.
- People with fat-malabsorption conditions (Crohn's, celiac, cystic fibrosis, liver disease)
- Individuals with abetalipoproteinemia or AVED (genetic)
- Premature infants
- People on very-low-fat diets for extended periods
- Older adults with poor dietary variety (marginal status common)
What causes low Vitamin E — a fat-soluble vitamin and the body's primary lipid-soluble antioxidant, comprising eight naturally occurring forms: four tocopherols (alpha, beta, gamma, delta) and four tocotrienols. Alpha-tocopherol is the only form maintained in human blood and tissues at meaningful levels and the only form the body uses to meet vitamin E requirements — it is the form in supplements and the basis of the RDA. RDA for adults: 15 mg (22.4 IU) alpha-tocopherol/day; UL: 1,000 mg/day from supplements (due to anticoagulant effects at high doses). Dietary sources: vegetable oils (wheat germ oil is the richest source — roughly 20 mg per tablespoon; sunflower oil, safflower oil, soybean oil); nuts and seeds (almonds: roughly 7 mg per oz; sunflower seeds); green leafy vegetables (spinach, broccoli — modest amounts); fortified cereals.
- Fat malabsorption conditions: Crohn's disease, celiac disease, cystic fibrosis (the primary acquired cause in adults and children), short bowel syndrome, biliary obstruction, primary biliary cholangitis, pancreatitis.
- Abetalipoproteinemia — genetic inability to make apolipoprotein B, preventing chylomicron formation; severe vitamin E deficiency results.
- AVED (ataxia with vitamin E deficiency) — genetic mutation in alpha-TTP gene; vitamin E absorbed normally but not retained in blood.
- Very-low-fat diet sustained over years (uncommon in adults — fat is ubiquitous in typical diets).
- Premature infants — inadequate vitamin E stores at birth.
How low levels are diagnosed
Serum alpha-tocopherol concentration — deficiency defined as below 12 mcmol/L (or below 5 mcg/mL); must be interpreted relative to total serum lipids (ratio of alpha-tocopherol to total lipid or cholesterol) because high blood lipids elevate serum E levels. For genetic disorders: genetic testing for alpha-TTP or apoB mutations.
How it's corrected
Most gaps close with food first, and supplementation when a clinician recommends it.
Food sources: wheat germ oil, sunflower/safflower oils, almonds, sunflower seeds, spinach, broccoli, fortified cereals. For fat-malabsorption deficiency: water-soluble vitamin E formulations (tocopheryl polyethylene glycol succinate — TPGS) may be needed because standard fat-soluble supplements cannot be absorbed without bile salts. For AVED: high-dose vitamin E supplementation (800–1,200 mg/day alpha-tocopherol) reverses neurological progression if started early. Standard supplement doses: 15–400 mg/day; doses above 400 IU/day (268 mg) have been associated in meta-analyses with increased all-cause mortality at very high doses.
How to keep levels up
Varied diet including oils, nuts, and seeds for most adults. Fat-malabsorption patients should have serum vitamin E monitored and may need supplementation. Premature infants receive supplemental vitamin E in neonatal units. For AVED: early identification via genetic testing in families with history of progressive ataxia of unknown cause.
When to see a clinician
Immediately for progressive ataxia or sensory neuropathy, particularly if you have a fat-malabsorption condition. For premature infants with suspected deficiency — neonatal care team. For AVED or abetalipoproteinemia — neurologist experienced with these conditions.
Vitamin E Deficiency Is Rare in Healthy Adults — But Serious When It Occurs
Vitamin E deficiency is not something most healthy adults need to worry about. The vitamin is abundant in plant oils, nuts, and seeds — foods that are nearly impossible to avoid in a typical Western diet — and the body has an efficient system for hanging onto it.
The liver produces a protein called alpha-tocopherol transfer protein (alpha-TTP) that selectively grabs alpha-tocopherol from the bloodstream and repackages it into VLDL particles for distribution to tissues. This recycling mechanism means the body maintains vitamin E reserves in adipose tissue and can go long periods without dietary intake before deficiency develops.
But when deficiency does occur, it is not a mild nutritional shortfall. Severe, prolonged vitamin E deficiency causes progressive and potentially irreversible neurological damage. The hallmark is spinocerebellar ataxia — a loss of coordination and balance that worsens over time — along with peripheral neuropathy (numbness, tingling, loss of sensation in the hands and feet) and muscle weakness. In premature infants, who have almost no vitamin E stores at birth, deficiency can cause hemolytic anemia and retinal damage.
This page is written for three audiences: people with fat-malabsorption conditions who need to understand their genuine risk, anyone with unexplained progressive neurological symptoms searching for answers, and those wondering whether their vitamin E supplement is actually necessary or potentially harmful.
Bottom line
Vitamin E deficiency is not a common concern for healthy adults, but it is a genuine risk for anyone with fat malabsorption — and the neurological consequences (ataxia, peripheral neuropathy) can be serious and progressive.
The Fat-Malabsorption Connection: Crohn's, Celiac, Cystic Fibrosis, and Liver Disease
Vitamin E is fat-soluble, which means it requires dietary fat and bile salts for absorption in the small intestine. Any condition that disrupts fat digestion or absorption creates deficiency risk — not just for vitamin E, but for all four fat-soluble vitamins (A, D, E, K).
Cystic fibrosis is the single most common cause of clinically significant vitamin E deficiency in high-income countries. The thick mucus characteristic of CF blocks pancreatic ducts, preventing digestive enzymes from reaching the small intestine. Without these enzymes, dietary fat passes through undigested, taking fat-soluble vitamins with it. Vitamin E deficiency is one of the most common nutritional complications of CF, and standard fat-soluble supplements often do not work because they still require bile salts and fat digestion for absorption.
The solution for CF patients — and others with severe fat malabsorption — is a water-soluble form of vitamin E called tocopheryl polyethylene glycol succinate (TPGS). TPGS forms micelles in the intestine without needing bile salts, allowing direct absorption. This formulation is a critical distinction: a person with CF who takes standard vitamin E capsules may see no improvement in serum levels, while the same dose as TPGS corrects the deficiency.
Crohn's disease creates vitamin E risk through a different mechanism. Inflammation and surgical resection of the terminal ileum — the section of small intestine where bile acids are reabsorbed — can deplete the bile acid pool, impairing fat absorption. Celiac disease causes villous atrophy that reduces the total absorptive surface area of the small intestine. Chronic liver disease and biliary obstruction reduce bile production directly. In all these conditions, serum vitamin E should be monitored periodically, and supplementation — often with TPGS — should be guided by lab values, not guesswork.
Bottom line
Cystic fibrosis is the single most common cause of clinically significant vitamin E deficiency in high-income countries — and it requires water-soluble E formulations, not standard supplements.
AVED and Abetalipoproteinemia: The Genetic Causes of Severe Vitamin E Deficiency
Two rare genetic disorders cause severe vitamin E deficiency through completely different mechanisms — and understanding the distinction matters because one of them is treatable if caught early.
AVED (ataxia with vitamin E deficiency) is an autosomal recessive disorder caused by mutations in the TTPA gene, which encodes the alpha-tocopherol transfer protein. People with AVED absorb vitamin E normally from food, but without functional alpha-TTP, the liver cannot retain it or repackage it for distribution. The vitamin is rapidly excreted, and serum levels plummet. The result is progressive spinocerebellar ataxia that typically begins in childhood or adolescence — loss of coordination, slurred speech, and gait disturbance that looks nearly identical to Friedreich's ataxia, a much more common inherited ataxia.
The critical clinical distinction: AVED responds to high-dose vitamin E supplementation (800–1,200 mg/day), while Friedreich's ataxia does not. Starting supplementation early — before irreversible neurological damage occurs — can halt disease progression and, in some cases, partially reverse symptoms. This makes genetic testing for TTPA mutations essential in any young patient presenting with unexplained progressive ataxia.
Abetalipoproteinemia is even rarer and more severe. Caused by mutations in the MTTP gene, it prevents the formation of apolipoprotein B, which is required to build chylomicrons and VLDL particles. Without these lipoprotein carriers, dietary fat cannot be transported from the intestine, and fat-soluble vitamins — including vitamin E — are never delivered to tissues. The condition presents in infancy with failure to thrive, steatorrhea, and progressive neurological and retinal degeneration. Treatment requires massive doses of vitamin E (100–300 mg/kg/day) along with vitamins A, D, and K, and a very-low-fat diet with medium-chain triglyceride supplementation.
Bottom line
AVED and abetalipoproteinemia are rare but important causes of severe vitamin E deficiency; AVED specifically responds to high-dose supplementation — making early genetic diagnosis in young patients with unexplained ataxia genuinely life-altering.
Vitamin E Supplements at High Doses: The Antioxidant Paradox and Mortality Signal
Vitamin E's reputation as a powerful antioxidant made it one of the most popular supplements of the 1990s and 2000s. The logic seemed sound: oxidative damage contributes to heart disease, cancer, and aging, so an antioxidant vitamin should reduce that damage. Large, well-designed randomized controlled trials tested this hypothesis — and the results were sobering.
The HOPE trial tested 400 IU/day of vitamin E in people with cardiovascular disease or diabetes and found no reduction in cardiovascular events, stroke, or mortality. The SELECT trial tested vitamin E and selenium for prostate cancer prevention in over 35,000 men and was stopped early when an interim analysis showed no benefit and a non-significant increase in prostate cancer in the vitamin E group. The GISSI-Prevenzione trial found a reduction in cardiovascular death with vitamin E — but only in a post-hoc subgroup analysis that was not confirmed in subsequent trials.
The most concerning signal came from a 2005 meta-analysis by Miller and colleagues, published in the Annals of Internal Medicine, which pooled 19 clinical trials and found a dose-dependent increase in all-cause mortality at vitamin E doses above 400 IU/day. The absolute risk increase was small, but the dose-response relationship was statistically significant — and it contradicted the widespread assumption that vitamin E was harmless at any dose.
There is also a mechanistic concern. The 'antioxidant paradox' suggests that high-dose antioxidant supplementation may blunt adaptive cellular stress responses — including the beneficial oxidative signaling that drives exercise-induced mitochondrial biogenesis and, potentially, the pro-oxidant mechanisms some chemotherapy drugs rely on to kill cancer cells. The NIH Office of Dietary Supplements is clear: supplementation above the UL (1,000 mg/day) and above 400 IU/day carries meaningful risk signals with no proven benefit in healthy adults.
Bottom line
High-dose vitamin E supplements (above 400 IU/day) have no proven benefit in healthy adults and carry a mortality signal in meta-analysis — one of the strongest evidence-based reasons to avoid mega-dose antioxidant supplementation.
Vitamin E and GLP-1 Therapy: NASH, Oxidative Stress, and the Supplement Reality
There is one evidence-based use case for high-dose vitamin E that stands apart from the generally negative supplement data: non-alcoholic steatohepatitis (NASH), the inflammatory form of fatty liver disease that can progress to cirrhosis.
The American Association for the Study of Liver Diseases (AASLD) guidelines recommend vitamin E at 800 IU/day as one of only two pharmacological treatments for NASH — specifically in non-diabetic adults without cirrhosis. (The other is pioglitazone.) The evidence comes from the PIVENS trial, which showed that vitamin E improved steatosis, inflammation, and ballooning on liver biopsy compared to placebo. This is a narrow, specific indication — it does not apply to simple fatty liver (NAFLD without inflammation), to people with diabetes, or to those with cirrhosis.
This matters for people on GLP-1 medications because NAFLD and NASH are extremely common in the population that seeks GLP-1 therapy for weight loss. GLP-1 drugs like semaglutide and tirzepatide improve NASH through metabolic mechanisms — weight loss, improved insulin sensitivity, reduced hepatic fat — while vitamin E targets oxidative stress in hepatocytes through a separate pathway. The two approaches are mechanistically non-redundant, though they have not been studied in combination.
There is no known pharmacokinetic interaction between alpha-tocopherol and GLP-1 receptor agonists. However, there is an important safety consideration: high-dose vitamin E inhibits platelet aggregation and can potentiate the effects of anticoagulants like warfarin. Many people on GLP-1 therapy have cardiovascular disease and may be on antiplatelet or anticoagulant medications — making this a clinically relevant interaction to discuss with a prescriber before adding high-dose vitamin E.
Bottom line
Vitamin E at 800 IU/day is a guideline-supported NASH treatment in non-diabetic adults — the one scenario where high-dose vitamin E supplementation has genuine evidence, making it the honest GLP-1 nexus for this page.
What most pages leave out
Most supplement-focused content ignores the large randomized trials showing no cardiovascular benefit from vitamin E and the meta-analysis linking high doses to increased mortality. The distinction between the narrow, evidence-based NASH use case and general supplementation is almost never drawn, and the anticoagulation risk at high doses is consistently under-reported.
We flag this so you can make an informed choice — not to scare you off.
❓Frequently Asked Questions
The main symptoms are peripheral neuropathy (numbness, tingling, loss of proprioception), spinocerebellar ataxia (progressive loss of coordination and balance), muscle weakness, and retinal damage. In premature infants, hemolytic anemia is a key sign. These symptoms typically occur in people with fat-malabsorption conditions, not from low dietary intake in healthy adults.
People with fat-malabsorption conditions — cystic fibrosis, Crohn's disease, celiac disease, and chronic liver disease — are at highest risk. Premature infants and people with rare genetic conditions (AVED, abetalipoproteinemia) are also vulnerable. Healthy adults eating a normal diet rarely develop deficiency.
No. Large randomized controlled trials, including HOPE and SELECT, found no cardiovascular benefit from vitamin E supplementation. The antioxidant hypothesis for heart disease has not been validated in clinical trials, and high doses may increase risk.
Wheat germ oil is the richest source, providing roughly 20 mg per tablespoon. Sunflower and safflower oils, almonds (roughly 7 mg per ounce), sunflower seeds, and spinach are also excellent sources.
Yes, in a specific context. Vitamin E at 800 IU/day is one of only two treatments with AASLD guideline support for NASH in non-diabetic adults without cirrhosis. This is the one evidence-based high-dose use case, and it does not apply to simple fatty liver or to people with diabetes.
High-dose supplementation above 400 IU/day is associated with a dose-dependent increase in all-cause mortality in meta-analysis. Vitamin E also inhibits platelet aggregation and can potentiate anticoagulants like warfarin at high doses. The tolerable upper limit is 1,000 mg/day, but risk signals appear at lower doses.
AVED is a rare autosomal recessive genetic disorder caused by mutations in the alpha-TTP gene. People with AVED absorb vitamin E normally but cannot retain it in circulation, leading to progressive ataxia that mimics Friedreich's ataxia. Unlike Friedreich's, AVED responds to high-dose vitamin E supplementation if started early.
Diagnosis is made by measuring serum alpha-tocopherol concentration — deficiency is defined as below 12 mcmol/L. This value must be interpreted relative to total serum lipids because high blood lipid levels can artificially elevate vitamin E readings. Anyone with a fat-malabsorption condition should have levels monitored regularly.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
Symptoms of Low Vitamin C: Causes and Treatment
Vitamin C deficiency (scurvy) still occurs today, causing bleeding gums, fatigue, and poor wound healing. Learn the symptoms, causes, and evidence-based treatment.
Read moreSymptoms of Low Vitamin K2: Causes and Treatment
Vitamin K2 deficiency symptoms include easy bruising and bleeding. Learn who's at risk, how it differs from K1, and the critical warfarin interaction.
Read moreSymptoms of Low Vitamin B: Causes and Treatment
Vitamin B deficiency isn't one condition—it's eight. Learn the distinct symptoms of B12, folate, B1, and B3 deficiency, who's at risk, and when to see a doctor.
Read moreSymptoms of Low Vitamin B2 (Riboflavin): Causes, Treatment, and Who Is at Risk
Riboflavin (B2) deficiency causes mouth sores, magenta tongue, and eye irritation. Learn who is at risk, how it's diagnosed, and how to treat it safely.
Read moreSymptoms of Low Vitamin B1 (Thiamine): Causes & Treatment
Thiamine deficiency can cause Wernicke encephalopathy, a medical emergency. Learn the symptoms of low vitamin B1, causes like alcohol use, and why IV treatment is critical.
Read moreSymptoms of Low Vitamin B3 (Niacin): Causes & Treatment
Niacin deficiency causes pellagra—the 'four Ds': dermatitis, diarrhea, dementia, and death. Learn the symptoms, causes, and how treatment differs from high-dose niacin.
Read moreOn a GLP-1, or thinking about one?
Nutrient gaps are more common on a GLP-1 because you eat less — care that includes real clinical oversight helps you do it safely.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door — no in-person clinic required
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.